Restoration of normal phenotype in cancer cells

Bissell, Mina J; Weaver, Valerie M

Title: Restoration of normal phenotype in cancer cells

Abstract

A method for reversing expression of malignant phenotype in cancer cells is described. The method comprises applying .beta..sub.1 integrin function-blocking antibody to the cells. The method can be used to assess the progress of cancer therapy. Human breast epithelial cells were shown to be particularly responsive.

Inventors:

Bissell, Mina J ^[1]; Weaver, Valerie M ^[2]

Berkeley, CA
Oakland, CA

Issue Date:: 1998-01-01

Research Org.:: Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)

OSTI Identifier:: 872022

Patent Number(s):: 5846536

Assignee:: Regents of University of California (Oakland, CA)

Patent Classifications (CPCs):: A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES

C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES

Show more

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A61K2039/505 - {comprising antibodies}
A61K38/00 - Medicinal preparations containing peptides

C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C07K16/2842 - {against integrin beta1-subunit-containing molecules, e.g. CD29, CD49}
C07K2317/55 - Fab or Fab'

C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES
C12N2500/25 - Insulin-transferrin
C12N2500/90 - Serum-free medium, which may still contain naturally-sourced components
C12N2501/11 - Epidermal growth factor [EGF]
C12N2501/315 - Prolactin
C12N2501/39 - Steroid hormones
C12N2501/392 - Sexual steroids
C12N2501/585 - Integrins
C12N2506/30 - from cancer cells, e.g. reversion of tumour cells
C12N5/0693 - {Tumour cells

Show less

DOE Contract Number:: AC03-76SF00098

Resource Type:: Patent

Country of Publication:: United States

Language:: English

Subject:: restoration; normal; phenotype; cancer; cells; method; reversing; expression; malignant; described; comprises; applying; beta; integrin; function-blocking; antibody; assess; progress; therapy; human; breast; epithelial; shown; particularly; responsive; method comprises; cancer therapy; comprises applying; method comprise; epithelial cells; cancer cells; reversing expression; normal phenotype; function-blocking antibody; integrin function-blocking; malignant phenotype; /424/530/

Citation Formats


                    Bissell, Mina J, and Weaver, Valerie M. Restoration of normal phenotype in cancer cells.  United States: N. p., 1998. 
        Web.

Copy to clipboard


                    Bissell, Mina J, & Weaver, Valerie M. Restoration of normal phenotype in cancer cells.  United States.

Copy to clipboard


                    Bissell, Mina J, and Weaver, Valerie M. Thu .  
        "Restoration of normal phenotype in cancer cells".  United States.  https://www.osti.gov/servlets/purl/872022.

Copy to clipboard


                    
@article{osti_872022,

  title        = {Restoration of normal phenotype in cancer cells},

  author       = {Bissell, Mina J and Weaver, Valerie M},

  abstractNote = {A method for reversing expression of malignant phenotype in cancer cells is described. The method comprises applying .beta..sub.1 integrin function-blocking antibody to the cells. The method can be used to assess the progress of cancer therapy. Human breast epithelial cells were shown to be particularly responsive.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {1998},

  month        = {1}

}

Copy to clipboard

Patent:

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Inhibition of Cell Attachment, Invasion and Metastasis of Human Carcinoma Cells by Anti-integrin β ₁ Subunit Antibody
journal, December 1992

Fujita, Shin; Suzuki, Hiroko; Kinoshita, Masao
Japanese Journal of Cancer Research, Vol. 83, Issue 12
https://doi.org/10.1111/j.1349-7006.1992.tb02764.x

Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity
journal, December 1991

Streuli, C. H.
The Journal of Cell Biology, Vol. 115, Issue 5
https://doi.org/10.1083/jcb.115.5.1383

Comparative evaluation of integrin ?- and ?-chain expression in colorectal carcinoma cell lines and in their tumours of origin
journal, October 1994

Koretz, K.; Br�derlein, S.; Henne, C.
Virchows Archiv, Vol. 425, Issue 3
https://doi.org/10.1007/BF00196144

Development of anin vitro extracellular matrix assay for studies of brain tumor cell invasion
journal, January 1994

Amar, Arun P.; DeArmond, Stephen J.; Spencer, Donna R.
Journal of Neuro-Oncology, Vol. 20, Issue 1
https://doi.org/10.1007/BF01057956

Another Anniversary for the War on Cancer
journal, March 1994

Dermer, Gerald B.
Bio/Technology, Vol. 12, Issue 3
https://doi.org/10.1038/nbt0394-320

Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells
journal, October 1992

Pignatelli, M.; Liu, D.; Nasim, Mm
British Journal of Cancer, Vol. 66, Issue 4
https://doi.org/10.1038/bjc.1992.328

Similar Records in DOE Patents and OSTI.GOV collections:

Method for restoration of normal phenotype in cancer cells

Patent Bissell, Mina J [Berkeley, CA]; Weaver, Valerie M [Oakland, CA]

A method for reversing expression of malignant phenotype in cancer cells is described. The method comprises applying .beta..sub.1 integrin function-blocking antibody to the cells. The method can be used to assess the progress of cancer therapy. Human breast epithelial cells were shown to be particularly responsive.
Full Text Available
Restoration of normal phenotype in cancer cells

Patent Bissell, M J; Weaver, V M

A method for reversing expression of malignant phenotype in cancer cells is described. The method comprises applying {beta}{sub 1} integrin function-blocking antibody to the cells. The method can be used to assess the progress of cancer therapy. Human breast epithelial cells were shown to be particularly responsive. 14 figs.
Laser-induced differential normalized fluorescence method for cancer diagnosis

Patent Vo-Dinh, Tuan [Knoxville, TN]; Panjehpour, Masoud [Knoxville, TN]; Overholt, Bergein F [Knoxville, TN]

An apparatus and method for cancer diagnosis are disclosed. The diagnostic method includes the steps of irradiating a tissue sample with monochromatic excitation light, producing a laser-induced fluorescence spectrum from emission radiation generated by interaction of the excitation light with the tissue sample, and dividing the intensity at each wavelength of the laser-induced fluorescence spectrum by the integrated area under the laser-induced fluorescence spectrum to produce a normalized spectrum. A mathematical difference between the normalized spectrum and an average value of a reference set of normalized spectra which correspond to normal tissues is calculated, which provides for amplifying small changesmore » « less
Full Text Available
Method of restoring degraded solar cells

Patent Staebler, David L [Lawrenceville, NJ]

Amorphous silicon solar cells have been shown to have efficiencies which degrade as a result of long exposure to light. Annealing such cells in air at a temperature of about 200.degree. C. for at least 30 minutes restores their efficiency.
Full Text Available
Combinational pixel-by-pixel and object-level classifying, segmenting, and agglomerating in performing quantitative image analysis that distinguishes between healthy non-cancerous and cancerous cell nuclei and delineates nuclear, cytoplasm, and stromal material objects from stained biological tissue materials

Patent Boucheron, Laura E

Quantitative object and spatial arrangement-level analysis of tissue are detailed using expert (pathologist) input to guide the classification process. A two-step method is disclosed for imaging tissue, by classifying one or more biological materials, e.g. nuclei, cytoplasm, and stroma, in the tissue into one or more identified classes on a pixel-by-pixel basis, and segmenting the identified classes to agglomerate one or more sets of identified pixels into segmented regions. Typically, the one or more biological materials comprises nuclear material, cytoplasm material, and stromal material. The method further allows a user to markup the image subsequent to the classification to re-classifymore » « less
Full Text Available

Similar Records

Title: Restoration of normal phenotype in cancer cells

Abstract

Citation Formats

Inhibition of Cell Attachment, Invasion and Metastasis of Human Carcinoma Cells by Anti-integrin β 1 Subunit Antibody journal, December 1992

Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity journal, December 1991

Comparative evaluation of integrin ?- and ?-chain expression in colorectal carcinoma cell lines and in their tumours of origin journal, October 1994

Development of anin vitro extracellular matrix assay for studies of brain tumor cell invasion journal, January 1994

Another Anniversary for the War on Cancer journal, March 1994

Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells journal, October 1992

Inhibition of Cell Attachment, Invasion and Metastasis of Human Carcinoma Cells by Anti-integrin β ₁ Subunit Antibody
journal, December 1992

Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity
journal, December 1991

Comparative evaluation of integrin ?- and ?-chain expression in colorectal carcinoma cell lines and in their tumours of origin
journal, October 1994

Development of anin vitro extracellular matrix assay for studies of brain tumor cell invasion
journal, January 1994

Another Anniversary for the War on Cancer
journal, March 1994

Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells
journal, October 1992